Dr Lee Shi Yan obtained her basic medical degree (MBBS) from Yong Loo Lin School of Medicine, National University of Singapore in 2018. She completed her Internal Medicine Residency training at NUH from 2018 to 2021, and obtained Membership of the Royal Colleges of Physicians of United Kingdom (MRCP) (UK) and Masters of Medicine (Internal Medicine) in 2021. Dr Lee Shi Yan pursued her Senior Residency training in Gastroenterology and Hepatology in NUH from 2021 to 2024, and was accredited as a Gastroenterology and Hepatology specialist in 2024 by the Specialty Accreditation Board (SAB) in Singapore. Her clinical and research interests are in liver cirrhosis, hepatocellular carcinoma and autoimmune diseases of the liver. She is involved in the undergraduate and post graduate education.
1. Lee SY, Nah BKY, Leo J, Koh JH, Huang DQ. Optimizing care of HBV infection and HBV-related HCC. Clin Liver Dis (Hoboken). 2024 Jun 21;23(1):e0169. doi: 10.1097/CLD.0000000000000169. PMID: 38911998; PMCID: PMC11192014.
2. Lee SY, Tan DJH, Lim WH, Ng CH, Muthiah M, Huang DQ. Clinical utility of non-invasive tests to predict clinical outcomes in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):916-918. doi: 10.21037/hbsn-23-460. Epub 2023 Nov 1. PMID: 38115945; PMCID: PMC10727826.
3. Lee SY, Lai H, Chua YJ, Wang MX, Lee GH. Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis. Frontiers in Medicine. 2022 ;9:880749. DOI: 10.3389/fmed.2022.880749. PMID: 35615095; PMCID: PMC9124896.
